Effects of erythropoietin on blood-brain barrier disruption in focal cerebral ischemia

Pharmacology

Volumn 82, Issue 1, 2008, Pages 38-42

  Chi, Oak Z ^a   Hunter, Christine ^a   Liu, Xia ^a   Weiss, Harvey R ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Blood brain barrier; Erythropoietin; Focal cerebral ischemia

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESEARCH; HEMODYNAMICS; MALE; MEMBRANE DAMAGE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINOISOBUTYRIC ACIDS; ANIMALS; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; CEREBRAL CORTEX; ERYTHROPOIETIN, RECOMBINANT; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAPERITONEAL; ISCHEMIC ATTACK, TRANSIENT; MALE; RATS; RATS, WISTAR;

EID: 46449117875     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000127839     Document Type: Article

References (34)

1. Albayrak S, Zhao Q, Siesjo BK, Smith ML: Effect of transient focal ischemia on BBB permeability in the rat: correlation to cell injury. Acta Neuropathol (Berl) 1997;94:158-163.
2. 2 supply/consumption heterogeneity. J Cereb Blood Flow Metab 1996;16:327-333.
3. Murakami K, Kondo T, Chan PH: Bloodbrain barrier disruption, edema formation and apoptotic neuronal death following cold injury. Acta Neurochir Suppl (Wien) 1997;70:234-236.
4. Semenza GL: Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology 2004;19:176-182.
5. Spandou E, Papoutsopoulou S, Soubasi V, Karkavelas G, Simeonidou C, Kremenopoulos G, Guiba-Tziampiri O: Hypoxia-ischemia affects erythropoietin receptor expression pattern in the neonatal rat brain. Brain Res 2004;1021:167-172.
6. Bernaudin M, Nedelec AC, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P: Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin, and VEGF in the adult mouse brain. J Cereb Blood Flow Metab 2002;22:393-403.
7. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, Brines M, Ghezzi P: Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 2003;198:971-975.
8. Zhang F, Signore AP, Zhou Z, Wang S, Cao G, Chen J: Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms. J Neurosci Res 2006;83:1241-1251.
9. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A: Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000;97:10526-10531.
10. Grasso G, Buemi M, Alafaci C, Sfacteria A, Passalacqua M, Sturiale A, Calapai G, de Vico G, Piedimonte G, Salpietro FM, Tomasello F: Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci USA 2002;99:5627-5631.
11. Martinez-Estrada OM, Rodriguez-Millan E, Gonzalez-de Vicente E, Reina M, Vilaro S, Fabre M: Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J Neurosci 2003;18:2538-2544.
12. Üzüm G, Diler AS, Bahcekapili N, Ziylan YZ: Erythropoietin prevents the increase in blood-brain barrier permeability during pentylentetrazol induced seizures. Life Sci 2006;78:2571-2576.
13. Malhotra S, Savitz SI, Ocava L, Rosenbaum DM: Ischemic preconditioning is mediated by erythropoietin through PI-3 kinase signaling in an animal model of transient ischemic attack. J Neurosci Res 2006;83:19-27.
14. Wang X, Ellison JA, Siren AL, Lysko PG, Yue TL, Barone FC, Shatzman A, Feuerstein GZ: Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat. J Neurochem 1998;71:1194-1204.
15. Gross PM, Blasberg RG, Fenstermacher JD, Patlak CS: The microcirculation of rat circumventricular organs and pituitary gland. Brain Res Bull 1987;18:73-85.
16. Chi OZ, Liu X, Weiss HR: Effects of 17β-estradiol on blood-brain barrier disruption during focal ischemia in rats. Horm Metab Res 2002;34:530-534.
17. Chi OZ, Hunter C, Liu X, Weiss HR: Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex. Neurol Res 2005;27:864-868.
18. Kristian T, Siesjo BK: Calcium in ischemic cell death. Stroke 1998;29:705-718.
19. Iadecola C: Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997;20:132-139.
20. Chi OZ, Wei HM, Sinha AK, Weiss HR: Effects of inhibition of nitric oxide synthase on blood-brain barrier transport in focal cerebral ischemia. Pharmacology 1994;48:367-373.
21. Chi OZ, Chang Q, Weiss HR: Effects of topical N-methyl-D- aspartate on blood-brain barrier permeability in the cerebral cortex of normotensive and hypertensive rats. Neurol Res 1997;19:539-544.
22. Kumral A, Ozer E, Yilmaz O, Akhisaroglu M, Gokmen N, Duman N, Ulukus C, Genc S, Ozkan H: Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 2003;83:224-228.
23. Wen TC, Rogido M, Genetta T, Sola A: Permanent focal cerebral ischemia activates erythropoietin receptor in the neonatal rat brain. Neurosci Lett 2004;355:165-168.
24. Leker RR, Teichner A, Ovadia H, Keshet E, Reinherz E, Ben-Hur T: Expression of endothelial nitric oxide synthase in the ischemic penumbra: relationship to expression of neuronal nitric oxide synthase and vascular endothelial growth factor. Brain Res 2001;909:1-7.
25. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R: Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997;76:105-116.
26. Nakano M, Satoh K, Fukumoto Y, Ito Y, Kagaya Y, Ishii N, Sugamura K, Shimokawa H: Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice. Circ Res 2007;100:662-669.
27. Lee M, Choi D, Choi MJ, Jeong JH, Kim WJ, Oh S, Kim YH, Bull DA, Kim SW: Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3′-untranslated region for the VEGF gene therapy. J Control Release 2006;115:113-119.
28. Gelinas DS, Bernatchez PN, Rollin S, Bazan NG, Sirois MG: Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways. Br J Pharmacol 2002;137:1021-1030.
29. Morikawa E, Moskowitz MA, Huang Z, Yoshida T, Irikura K, Dalkara T: L-Arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 1994;25:429-435.
30. Santhanam AV, Katusic ZS: Erythropoietin and cerebral vascular protection: role of nitric oxide. Acta Pharmacol Sin 2006;27:1389-1394.
31. Banerjee D, Rodriguez M, Nag M, Adamson JW: Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity. Kidney Int 2000;57:1895-1904.
32. Eid T, Brines M: Recombinant human erythropoietin for neuroprotection: what is the evidence? Clin Breast Cancer 2002;3:S109-S115.
33. Wiessner C, Allegrini PR, Ekatodramis D, Jewell UR, Stallmach T, Gassmann M: Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab 2001;21:857-864.
34. Smith KJ, Bleyer AJ, Little WC, Sane DC: The cardiovascular effects of erythropoietin. Cardiovasc Res 2003;59:538-548.